Click on the links below to view abstracts and posters presented at this congress. All copyright remains that of the copyright holder. This page will be available for a limited period after the congress.
Poster presentations
Tuesday 17 September 2019
12:00 PM–1:00 PM PS 055 Extra-glycaemic effects of GLP-1 receptor agonists Poster Hall
1:15 PM–2:15 PM PS 062 Making diabetes care more cost-effective Poster Hall
Poster presentation 753 Blundell (Gibbons)
Oral semaglutide reduces appetite and energy intake and improves control of eating in subjects with type 2 diabetes
View PDF
Poster presentation 821 Löndahl
Cost-effectiveness of once-weekly semaglutide versus empagliflozin in people with type 2 diabetes and inadequate glycaemic control in Sweden
View PDF
Poster presentation 754 Wilding
Weight loss induced by semaglutide once weekly contributes to improved health-related quality of life and treatment satisfaction
View PDF
Poster presentation 756 Leiter
Liraglutide and semaglutide improve cardiovascular and renal outcomes across baseline BP categories: analysis of LEADER and SUSTAIN 6
View PDF
Poster presentation 757 Bain
The effect of once-weekly semaglutide on MACE, blood pressure and lipids by race and ethnicity: a SUSTAIN 6 post hoc analysiss
View PDF
Poster presentation 758 Zinman
Impact of microvascular disease on cardiorenal outcomes in type 2 diabetes: an analysis from the LEADER and SUSTAIN 6 clinical trials
View PDF